These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 6545400

  • 21. [Desferrioxamine B treatment of 4 splenectomized cases of Cooley's anemia].
    Rossi R, Frangini V, Pratesi C.
    Riv Clin Pediatr; 1968; 81(5):1002-9. PubMed ID: 5740180
    [No Abstract] [Full Text] [Related]

  • 22. [Longitudinal growth of patients with homozygote beta-thalassemia during continuous subcutaneous infusion of deferoxamine].
    Krüger N, Stubbe P, Tillmann W, Schröter W.
    Dtsch Med Wochenschr; 1986 Jan 31; 111(5):176-81. PubMed ID: 3943469
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Effects of desferrioxamine on iron elimination in children after multiple transfusions].
    Leggio ML.
    Minerva Pediatr; 1966 Feb 04; 18(3):101-3. PubMed ID: 5930397
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reassessment of the use of desferrioxamine B in iron overload.
    Propper RD, Shurin SB, Nathan DG.
    N Engl J Med; 1976 Jun 24; 294(26):1421-3. PubMed ID: 1272274
    [Abstract] [Full Text] [Related]

  • 31. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
    el-Gholmy A, Khalifa AS, Rahman YA, el-Bagoury I.
    J Trop Med Hyg; 1969 Jan 24; 72(1):22-6. PubMed ID: 5773810
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vitamin C and iron.
    Nienhuis AW.
    N Engl J Med; 1981 Jan 15; 304(3):170-1. PubMed ID: 7442737
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
    Girot R, Thévenin M, Bouveret JP, Jeannel F, Rymer JC.
    Arch Fr Pediatr; 1980 Apr 15; 37(4):241-7. PubMed ID: 7406638
    [Abstract] [Full Text] [Related]

  • 37. [Role and therapeutic use of deferoxamine in iron overload due to thalassemia (author's transl)].
    Lévy G, Bachelot C, Joannard A, Bost M.
    Arch Fr Pediatr; 1980 May 15; 37(5):299-303. PubMed ID: 7469704
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Current management of homozygous beta thalassemia.
    Choudhry VP, Desai N, Pati HP, Nanu A.
    Indian Pediatr; 1991 Oct 15; 28(10):1221-9. PubMed ID: 1724659
    [No Abstract] [Full Text] [Related]

  • 40. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P, Giua R, De Marco S, Bonetti MG, Amurri B, Masi C, Lazzari G, Rizzo C, Cervellera M, Peluso A.
    Haematologica; 1995 Oct 15; 80(5):398-404. PubMed ID: 8566878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.